ArticleJCO precision oncology2022

Cost-Effectiveness of Parallel Versus Sequential Testing of Genetic Aberrations for Stage IV Non-Small-Cell Lung Cancer in the Netherlands.

Henri B Wolff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.